Opinion|Videos|November 25, 2024
Genetic Screening for IgAN
Key Takeaways
- Familial IgA nephropathy constitutes up to 15% of cases, prompting consideration of family member screening.
- No consensus exists on routine screening, but monitoring first-degree relatives may be advisable.
Panelists discuss the importance of screening and monitoring family members of individuals with IgA nephropathy, noting that up to 15% of cases are familial and outlining recommendations for the frequency of such assessments.
Advertisement
Episodes in this series
- Up to 15% of IgA nephropathy (IgAN) cases are considered familial, should. Should family members of individuals with IgAN be screened or monitored for signs of the disease? If yes, how often?
Advertisement
Related to this article
Robert Mentz, MD, discusses mentorship, trial recruitment, journal growth, and surgical partnerships in heart failure care.
Advertisement
Advertisement
Trending on HCPLive
1
Cannabis Use Tied to Higher Odds of Stroke, Cardiovascular Disease
2
STREAM: Statin Discontinuation Noninferior in Older Adults Without CVD
3
AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke
4
Common Diuretic Linked to Home Blood Pressure Lowering After Stroke
5